@ScottGottliebMD @megtirrell And if IPAB isn’t operational, power devolves to HHS Secretary and he/she can allow “negotiations”
RT @RealClearFrezza: [email protected] describes h…
posted on September 4, 2016 by
RT @RealClearFrezza: [email protected] describes how FDA creates expensive barriers to market that led to the EpiPen drug pricing debacle youtu.be/1766165lGhY
Retweeted Scott Gottlieb, MD (@ScottGottliebMD):…
posted on April 29, 2016 by
Retweeted Scott Gottlieb, MD (@ScottGottliebMD): Health Care is The Greatest Financial Concern Among American… fb.me/7IOjqX1dV
Retweeted Scott Gottlieb, MD (@ScottGottliebMD):…
posted on April 28, 2016 by
Retweeted Scott Gottlieb, MD (@ScottGottliebMD): Good explainer on a game changer of a new rule that will have… fb.me/5SR6na2Pn
Retweeted Scott Gottlieb, MD (@ScottGottliebMD):…
posted on April 26, 2016 by
Retweeted Scott Gottlieb, MD (@ScottGottliebMD): CMS mega reg overhauling Medicaid MCOs: Rule:… fb.me/8buQIs5at
@ScottGottliebMD Plus, cost sharing will likely in…
posted on April 16, 2016 by
@ScottGottliebMD Plus, cost sharing will likely increase again, even fewer product offerings, few if any PPOs. Messy.
Retweeted Scott Gottlieb, MD (@ScottGottliebMD):…
posted on April 3, 2016 by
Retweeted Scott Gottlieb, MD (@ScottGottliebMD): Drug pricing is very clearly on the mind of new @CMSGov chief…. fb.me/ycVlnWrs
